Cargando…

Severe Cutaneous Adverse Reaction (SCAR): Clinical Pharmacologists’ Viewpoint

Detalles Bibliográficos
Autores principales:	Shafiq, Nusrat, Bhattacharjee, Samiksha, Malhotra, Samir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Guest Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809142/ https://www.ncbi.nlm.nih.gov/pubmed/35198462 http://dx.doi.org/10.4103/idoj.idoj_2_22

Ejemplares similares

Chemokines in Severe Cutaneous Adverse Reactions (SCARs)
por: Miyagawa, Fumi, et al.
Publicado: (2021)

On the clinical significance of cutaneous melanoma's precursors
por: Noto, Giuseppe
Publicado: (2012)

Most cherished moments of STAR pharmacologists
por: Rathnam, Shivprakash, et al.
Publicado: (2021)

Drugs in sport: The curse of doping and role of pharmacologist
por: Mahendru, Dhruv, et al.
Publicado: (2019)

Clinical pharmacologist from the eyes of a clinical pharmacologist: a questionnaire-based survey
por: Krishnamurthy, Manjunath Nookala, et al.
Publicado: (2022)

Pharmacovigilance and Pharmacoepidemiology as a Guarantee of Patient Safety: The Role of the Clinical Pharmacologist
por: Crescioli, Giada, et al.
Publicado: (2022)

The pharmacologist’s fertility
por: Papadimos, Thomas J.
Publicado: (2013)

Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)
por: James, Fiona, et al.
Publicado: (2022)

Push, promote or educate…musings of a pharmacologist on drug promotion
por: Shashindran, Chanolean
Publicado: (2014)

Severe Cutaneous Adverse Reactions Caused by Anti-Tubercular Drugs
por: Kim, Sang-Heon
Publicado: (2021)

The future trajectory of adverse outcome pathways: a commentary
por: Sewell, Fiona, et al.
Publicado: (2018)

Psychosocial adversity and mental illness: Differentiating distress, contextualizing diagnosis
por: Jacob, K. S.
Publicado: (2013)

Intraocular devices associated adverse events reporting system in India
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2020)

Journey of a therapeutic poison: Botulinum toxin A and its biosimilars
por: Bhattacharjee, Kasturi, et al.
Publicado: (2021)

Sutton's law and severe cutaneous adverse drug reactions: Is the money in the blister?
por: Chow, Timothy G., et al.
Publicado: (2021)

Case reporting and metal reaction: the big picture
por: Van Citters, Douglas W.
Publicado: (2015)

Role of pharmacologists in clinical research: The onus is on us
por: Singh, Jagjit
Publicado: (2013)

Tolerated drugs in subjects with severe cutaneous adverse reactions (SCARs) induced by anticonvulsants and review of the literature
por: De Luca, Fabrizio, et al.
Publicado: (2017)

Recent Advances in Severe Cutaneous Adverse Drug Reaction
por: Das, Sudip, et al.
Publicado: (2018)

Triptans: the experience of a clinical pharmacologist in clinical practice
por: Pini, Luigi Alberto, et al.
Publicado: (2001)

ISA academics – A new era
por: Malhotra, Naveen
Publicado: (2020)

Severe Cutaneous Adverse Reactions in Korean Pediatric Patients: A Study From the Korea SCAR Registry
por: Oh, Hea Lin, et al.
Publicado: (2019)

Artificial intelligence in drug development: clinical pharmacologist perspective
por: Jang, In-Jin
Publicado: (2019)

Perspectives on training quantitative systems pharmacologists
por: Zhang, Tongli, et al.
Publicado: (2022)

Statistics and experimental design for toxicologists and pharmacologists /
por: Gad, Shayne C., 1948-
Publicado: (2005)

Mental Health Matters: Celebrating 1(st) Foundation Day of Indian Psychiatric Society
por: Malhotra, Savita, et al.
Publicado: (2021)

A Critical Look at the Methodology of Epidemiological Studies
por: Grover, Sandeep, et al.
Publicado: (2019)

Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR registry
por: Kim, Min-Hye, et al.
Publicado: (2023)

Treatments for Severe Cutaneous Adverse Reactions
por: Cho, Yung-Tsu, et al.
Publicado: (2017)

Genetics of Severe Cutaneous Adverse Reactions
por: Yang, Shang-Chen, et al.
Publicado: (2021)

Mini‐Symposium Severe acute respiratory syndrome (SARS): Reshaping global public health
por: Olowokure, Babatunde, et al.
Publicado: (2006)

Personalized medicine: myth or reality? The position of Russian clinical pharmacologists
por: Zhestovskaja, Anna S, et al.
Publicado: (2013)

The Relationship between Hospital-Based Clinical Pharmacologists and the Pharmaceutical Industry
por: Parsons, R. L.
Publicado: (1979)

Beta-blockers in cardiac arrhythmias–Clinical pharmacologist’s point of view
por: Wołowiec, Łukasz, et al.
Publicado: (2023)

Clinical engineering and uncertainty in clinical measurements
por: Koumoundouros, Emmanuel
Publicado: (2014)

Bridging the gap… From clinical research to clinical practice
por: Kohli, Anil
Publicado: (2008)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis
por: Steenblock, Charlotte, et al.
Publicado: (2020)

Sports Pharmacology: A Medical Pharmacologist’s Perspective
por: Malve, Harshad O.
Publicado: (2018)

Louis Lewin, Pharmacologist, Toxicologist, Medical Historian
por: Macht, David I.
Publicado: (1931)

The association of pre-existing comorbid conditions with COVID-19 severity and post-COVID complications; insights from South Asia
por: Saeed, Sahrai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5odrigoclpdr8sj88o2dg7ivin